Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)
China flag China · Delayed Price · Currency is CNY
71.09
-1.22 (-1.69%)
Sep 9, 2025, 3:00 PM CST

Jiangsu Hengrui Medicine Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
26,56825,01022,37721,21325,78027,613
Upgrade
Other Revenue
3,5772,975442.662.25125.22121.91
Upgrade
30,14527,98522,82021,27525,90627,735
Upgrade
Revenue Growth (YoY)
19.38%22.63%7.26%-17.87%-6.59%19.09%
Upgrade
Cost of Revenue
4,1483,8813,5623,5033,7563,356
Upgrade
Gross Profit
25,99724,10419,25717,77222,15024,379
Upgrade
Selling, General & Admin
11,45410,8929,9949,65412,24412,869
Upgrade
Research & Development
6,7736,5834,9544,8875,9434,989
Upgrade
Other Operating Expenses
326.79182.17149.03145.32201.81239.35
Upgrade
Operating Expenses
18,48717,62815,08114,71218,38518,107
Upgrade
Operating Income
7,5106,4764,1763,0603,7656,272
Upgrade
Interest Expense
-13.91-5.56-5.9-6.49-4.71-
Upgrade
Interest & Investment Income
491.36607.56477.14772.64580.9631.7
Upgrade
Currency Exchange Gain (Loss)
-40.8-24.047.993.19-22.42-101.97
Upgrade
Other Non Operating Income (Expenses)
240.04-0.610.74-1.37-198.97-3.89
Upgrade
EBT Excluding Unusual Items
8,1877,0534,6563,9184,1196,798
Upgrade
Gain (Loss) on Sale of Investments
206.33108.63-107.4176.536.2316.5
Upgrade
Gain (Loss) on Sale of Assets
5.695.43.164.231.642.98
Upgrade
Asset Writedown
-4.94-4.94-76.21-130--2.28
Upgrade
Other Unusual Items
74.97.55191.68100.11309.0480.67
Upgrade
Pretax Income
8,4697,1704,6673,9684,4666,895
Upgrade
Income Tax Expense
1,105832.7389.29153.35-17.72586.59
Upgrade
Earnings From Continuing Operations
7,3646,3374,2783,8154,4846,309
Upgrade
Minority Interest in Earnings
-8.65-0.4724.6291.2346.1919.49
Upgrade
Net Income
7,3556,3374,3023,9064,5306,328
Upgrade
Net Income to Common
7,3556,3374,3023,9064,5306,328
Upgrade
Net Income Growth
35.55%47.28%10.14%-13.77%-28.41%18.77%
Upgrade
Shares Outstanding (Basic)
6,3386,3376,3276,4046,3816,392
Upgrade
Shares Outstanding (Diluted)
6,3386,3376,3276,4046,3816,392
Upgrade
Shares Change (YoY)
0.62%0.15%-1.20%0.36%-0.18%-0.03%
Upgrade
EPS (Basic)
1.161.000.680.610.710.99
Upgrade
EPS (Diluted)
1.161.000.680.610.710.99
Upgrade
EPS Growth
34.72%47.06%11.47%-14.09%-28.28%18.80%
Upgrade
Free Cash Flow
6,4185,4546,160-726.912,5542,878
Upgrade
Free Cash Flow Per Share
1.010.860.97-0.110.400.45
Upgrade
Dividend Per Share
0.2000.2000.2000.1600.1600.167
Upgrade
Dividend Growth
--25.00%--4.02%4.32%
Upgrade
Gross Margin
86.24%86.13%84.39%83.53%85.50%87.90%
Upgrade
Operating Margin
24.91%23.14%18.30%14.38%14.53%22.61%
Upgrade
Profit Margin
24.40%22.64%18.85%18.36%17.49%22.82%
Upgrade
Free Cash Flow Margin
21.29%19.49%26.99%-3.42%9.86%10.38%
Upgrade
EBITDA
8,2837,1944,8433,5994,2606,720
Upgrade
EBITDA Margin
27.48%25.71%21.22%16.91%16.45%24.23%
Upgrade
D&A For EBITDA
772.19718.46666.52539.12495.59448.39
Upgrade
EBIT
7,5106,4764,1763,0603,7656,272
Upgrade
EBIT Margin
24.91%23.14%18.30%14.38%14.53%22.61%
Upgrade
Effective Tax Rate
13.05%11.61%8.34%3.86%-8.51%
Upgrade
Revenue as Reported
30,14527,98522,82021,27525,90627,735
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.